NCT05802927
Completed
Not Applicable
A Randomized Controlled Trial to Determine the Effects of Diabetes-specific Formula on Glycemic Control in Individuals With Type 2 Diabetes
ConditionsDiabetes Mellitus, Type 2
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes Mellitus, Type 2
- Sponsor
- Abbott Nutrition
- Enrollment
- 64
- Locations
- 2
- Primary Endpoint
- Postprandial blood glucose
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
A randomized, controlled, crossover design with three treatments to determine the effects of diabetes-specific formula on glycemic control in individuals with type 2 diabetes.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Postprandial blood glucose
Time Frame: 3 hours
Positive area under the curve (AUC) for blood glucose concentration from 0 to 180 minutes.
Secondary Outcomes
- Postprandial insulin(3 hours)
- Appetite(3 hours)
Study Sites (2)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Multi-Center, Randomized Controlled Clinical Investigation Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System in the Healing of Diabetic Foot UlcersDiabetic Foot UlcerNCT05519501Syntr Health Technologies, Inc.60
Completed
Not Applicable
Diabetes-Specific Formula in Individuals With Type 2 DiabetesDiabetes Mellitus, Type 2NCT04303754Abbott Nutrition100
Completed
Not Applicable
Evaluation of Glycemic Response in Individuals With Type 2 DiabetesGlycemic ControlNCT05165693Abbott Nutrition24
Completed
Not Applicable
Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes MellitusDiabetesNCT02856516Société des Produits Nestlé (SPN)12
Completed
Not Applicable
To Assess the Efficacy of Investigational Product on the Neuropathic Pain in Individuals Suffering From Type II Diabetes Mellitus.Diabetic NeuropathiesInsomnia Due to Medical ConditionNCT04504305Vedic Lifesciences Pvt. Ltd.64